InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
Intercure Ltd. (INCR)
US:NASDAQ Investor Relations:
investor.incresearch.com/investors
Company Research
Source: Business Wire
InterCure provides an update following recent Cannabis Reform in GermanyExpects to launch its first products in Germany in the coming monthsThe Company continues to closely watch developments surrounding Cannabis rescheduling in the U.S. NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company outside of North America, is thrilled to congratulate The Federal Republic of Germany for the passing of the “CannG” Cannabis Act, which is expected to take effect on April 1, 2024. On the backdrop of this monumental development, InterCure expects to launch a series of products in Germany in the coming months.While the Cannabis Act deals with all types of cannabis, it is poised to have a uniquely significant impact on the medical cannabis sector. By excising cannabis from the list of prohibited substances in the German Narcotics Act, the reform makes prescribing medical cannabis
Show less
Read more
Impact Snapshot
Event Time:
INCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCR alerts
High impacting Intercure Ltd. news events
Weekly update
A roundup of the hottest topics
INCR
News
- InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million [Yahoo! Finance]Yahoo! Finance
- InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 millionBusiness Wire
- InterCure Provides an Update Regarding Nir Oz FacilityGlobeNewswire
- InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy ChainGlobeNewswire
INCR
Sec Filings
- 4/1/24 - Form 6-K
- 2/13/24 - Form 6-K
- 2/13/24 - Form 6-K
- INCR's page on the SEC website